HealthCare Royalty Partners (“HCR”) is a private investment firm that purchases royalties and uses debt-like structures to invest in commercial or near-commercial stage biopharmaceutical assets. They target healthcare assets with significant clinical value and strong barriers to entry that are meaningful to their marketer. They also look for assets that will produce sustainable revenues over an extended period of time. Their investments span the pharmaceutical, biotechnology, and specialty pharmaceuticals sectors.

Investment Management

HealthCare Royalty Partners

Clarke B. Futch

Aaron B. Simon

Joshua C. House

Tolly Flinn

Hayden C.B. Futch

Collin G. Stewart

Timothy R.M. Bryant

Christopher A. White

Lauren C. Jorgensen

John A. Urquhart

Shin W. Kang

Warren D. Cooper

Carlos M. Almodóvar

Anthony G. Rapsomanikis

Spencer H. Schneider

Michele D. Romaniello

Rosa I. Mercado

Stephanie A. Gilbey

Thomas K. Conner

Leadership Team

Finance and Accounting

Business Development and Strategy

Administrative Support

Teams at HealthCare Royalty Partners

Leadership Team

Finance and Accounting

Business Development and Strategy

Administrative Support